AstraZeneca announced it will eliminate 700 positions across the United States by early next year, according to an article in USA Today. The company's headquarters in Delaware will lose about 120 employees.
"The remaining impacted roles are field-based roles across the US and include both sales and non-sales roles," said Abigail Bozrath, a company spokeswoman via email. "These changes are specific to the US Commercial Business and do not apply to other parts of the business, including Newark, or other US-based global employees."
Read the full story